Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite ...

Q4 FY26 earnings call: revenue +19%, strong margins, AI/cloud strategy, and FY27 guidance amid restructuring risk.

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Encouraging Results from Phase 2 HIT Trial On February 24, 2026, Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) announced encouraging results from ...

In cutting nearly 40% of its workforce, Block loudly professed that the days of AI taking the jobs of humans has arrived.

Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite no difference in platelet count recovery End-of-Phase ...

MTY Food Group (TSE:MTY) executives said the company ended fiscal 2025 with improving operating momentum despite a ...

A woman was fined $5,000 for repeatedly giving false information to CAD officers during a probe involving Tiong Bahru ...

A man who was accused of throwing rocks at Jewish UW-Madison students pleaded guilty to one count of misdemeanor disorderly ...

O'Connor discusses how Texas business personal property renditions are due April 15, 2026. HOUSTON, TX, UNITED STATES, ...

Cadrenal Therapeutics Inc (NASDAQ:CVKD) shares jumped 11% Tuesday after the company reported encouraging results from a Phase 2 trial of CAD-1005 in patients with ...

Heart disease remains the leading cause of death in the United States, but doctors say many people don't recognize the early warning signs until a major event happens.

A research-based profile of seven 3D scanning providers serving the New York City market across film, VFX, gaming, and ...